IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,461,542 | +10.5% | 775,787 | -4.1% | 0.04% | +5.9% |
| Q1 2023 | $4,942,782 | -5.7% | 808,966 | -1.3% | 0.03% | -24.4% |
| Q4 2022 | $5,238,931 | -76.4% | 819,864 | -64.6% | 0.04% | -71.0% |
| Q3 2022 | $22,199,000 | +12.0% | 2,317,217 | -21.1% | 0.16% | +32.5% |
| Q2 2022 | $19,816,000 | -60.8% | 2,935,679 | -3.4% | 0.12% | -44.5% |
| Q1 2022 | $50,573,000 | -63.2% | 3,037,443 | -57.8% | 0.21% | -49.3% |
| Q4 2021 | $137,477,000 | -52.1% | 7,201,518 | -38.2% | 0.42% | -39.7% |
| Q3 2021 | $287,285,000 | -40.2% | 11,649,837 | -36.9% | 0.69% | -22.7% |
| Q2 2021 | $480,088,000 | -23.1% | 18,450,713 | -6.5% | 0.89% | -28.0% |
| Q1 2021 | $624,546,000 | -12.0% | 19,726,650 | +29.0% | 1.24% | -34.3% |
| Q4 2020 | $709,819,000 | +172.8% | 15,297,822 | +93.6% | 1.89% | +22.4% |
| Q3 2020 | $260,177,000 | +123.8% | 7,903,308 | +86.6% | 1.54% | +23.4% |
| Q2 2020 | $116,258,000 | +337.8% | 4,235,273 | +377.4% | 1.25% | +88.8% |
| Q1 2020 | $26,558,000 | +16.5% | 887,179 | +7.8% | 0.66% | +15.1% |
| Q4 2019 | $22,790,000 | +53.7% | 823,344 | +1.0% | 0.58% | +77.5% |
| Q3 2019 | $14,829,000 | -25.1% | 814,796 | +0.9% | 0.32% | -35.1% |
| Q2 2019 | $19,805,000 | +201.2% | 807,688 | +16.8% | 0.50% | +165.4% |
| Q1 2019 | $6,576,000 | +2.3% | 691,494 | -4.8% | 0.19% | -28.0% |
| Q4 2018 | $6,428,000 | +34.5% | 726,360 | +71.0% | 0.26% | +81.2% |
| Q3 2018 | $4,779,000 | +204.4% | 424,820 | +246.4% | 0.14% | +148.3% |
| Q2 2018 | $1,570,000 | +42.7% | 122,623 | +88.4% | 0.06% | +5.5% |
| Q1 2018 | $1,100,000 | – | 65,096 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |